5817-92-5 | 2,4-Dioxo-4-phenylbutanoic acid

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$108.00	$76.00
5g	98%	in stock	$359.00	$252.00
10g	98%	in stock	$665.00	$466.00
25g	98%	in stock	$1,317.00	$922.00

Description

• Catalog Number: AG68508
• Chemical Name: 2,4-Dioxo-4-phenylbutanoic acid
• CAS Number: 5817-92-5
• Molecular Formula: C10H8O4
• Molecular Weight: 192.1681
• MDL Number: MFCD00456054
• SMILES: O=C(c1ccccc1)CC(=O)C(=O)O

Computed Properties

• Complexity: 251
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 4
• XLogP3: 1.2

Literature

• Discovery of N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as HCV NS5B polymerase inhibitors.

  ChemMedChem 20120501

• HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding.

  Molecular pharmaceutics 20110404

• Using small molecules to target protein phosphatases.

  Bioorganic & medicinal chemistry 20110401

• Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.

  PLoS pathogens 20100901

• RNA-dependent RNA polymerase of hepatitis C virus: study on inhibition by alpha,gamma-diketo acid derivatives.

  Biochemistry. Biokhimiia 20090801

• The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

  Nature 20090416

• [New strategy for targeting influenza virus replication].

  Medecine sciences : M/S 20090401

• A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.

  Biophysical journal 20080401

• Ethyl 3-benzoyl-2-hydroxy-prop-2-enoate.

  Acta crystallographica. Section E, Structure reports online 20080101

• Hepatitis C virus RNA-dependent RNA polymerase: study on the inhibition mechanism by pyrogallol derivatives.

  Biochemistry. Biokhimiia 20060901

• From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes.

  Journal of medicinal chemistry 20060713

• Control of hepatitis C: a medicinal chemistry perspective.

  Journal of medicinal chemistry 20050113

• Stereospecific synthesis of (R)-2-hydroxy carboxylic acids using recombinant E. coli BL21 overexpressing YiaE from Escherichia coli K12 and glucose dehydrogenase from Bacillus subtilis.

  Biotechnology progress 20050101

• Spectroscopic studies of diketoacids-metal interactions. A probing tool for the pharmacophoric intermetallic distance in the HIV-1 integrase active site.

  Journal of medicinal chemistry 20041021

• Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes.

  Bioorganic & medicinal chemistry letters 20040308

• Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase.

  Journal of medicinal chemistry 20040101

• Catalysis, stereochemistry, and inhibition of ureidoglycolate lyase.

  The Journal of biological chemistry 20031212

• Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.

  Journal of medicinal chemistry 20020718

• Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

  Antimicrobial agents and chemotherapy 19941201